CLX
CloroxPrevious close
88.00
Change
−0.67 / −0.76%
P/E (TTM) ?
18.7
Market Cap
$10.8B
1M
+8.63%
S&P 500 −0.91% over same period
Volume / Avg Volume
3.9M / 2.4M
1.59× average
Latest earnings analysisFY2026 Q4Reported 2026-08-03
Clorox Q4 FY26: sales -2.0%, gross margin 41.3%, EPS $1.34
Clorox's fiscal fourth quarter looked ugly on the surface and mostly has an explanation underneath: revenue fell 2.0% to $1.95 billion, gross margin dropped 520 basis points, and GAAP earnings per share halved to $1.34. The view is Neutral, because most of the damage is acquisition accounting and a one-year ERP shipment swing, while the FY27 plan still implies only thin organic growth and no margin recovery.
Read the full analysis →Revenue$1.95BYoY −2.00%
EPS (non-GAAP)$1.66Missest. $1.67
Next-day move+6.52%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q4 Quarter ended 2026-06 | 2026-08-03 | $1.9B | Read analysis → |
| FY2026 Q3 Quarter ended 2026-03 | 2026-04-30 | $1.7B | Pending |
| FY2026 Q2 Quarter ended 2025-12 | 2026-02-03 | $1.7B | Pending |
| FY2026 Q1 Quarter ended 2025-09 | 2025-11-03 | $1.4B | Pending |
| FY2025 Q4 Quarter ended 2025-06 | 2025-07-31 | $7.1B | Pending |
| FY2025 Q3 Quarter ended 2025-03 | 2025-05-05 | $1.7B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 30 of its 5-year rangeCheap
5-year range 14.5 – 263.5 · Median 51.5
Last 4 quarters: $331M in buybacks + $602M in dividends, 8.65% of market cap combined
P/E (TTM)
18.7
P/B
—
P/S
1.6
Dividend Yield
3.40%
Earnings Reaction
Over the last 6 reports, the stock moved ±4.0% on average on the first trading day after, rising 3 times
Most recent +6.52%
Volatility & Correlation
1-year beta 0.23 · Correlation with S&P 500 0.08Low beta
Annualized volatility 36% vs. 12% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 1.67 | +0.1% | 43.2% | 0.19 | 1.54 |
| FY2026 Q2 | 1.67 | −0.8% | 43.2% | 0.16 | 1.29 |
| FY2026 Q1 | 1.43 | −18.9% | 41.7% | 0.08 | 0.65 |
| FY2025 Q4 | 1.99 | +4.5% | 46.5% | 0.35 | 2.68 |
| FY2025 Q3 | 1.67 | −8.0% | 44.6% | 0.19 | 1.50 |
| FY2025 Q2 | 1.69 | −15.3% | 43.8% | 0.19 | 1.54 |
| FY2025 Q1 | 1.76 | +27.1% | 45.8% | 0.10 | 0.80 |
| FY2024 Q4 | 1.90 | −5.7% | 46.5% | 0.23 | 1.74 |
| FY2024 Q3 | 1.81 | −5.3% | 42.2% | -0.05 | -0.41 |
| FY2024 Q2 | 1.99 | +16.0% | 43.5% | 0.09 | 0.75 |
| FY2024 Q1 | 1.39 | −20.3% | 38.4% | 0.02 | 0.17 |
| FY2023 Q4 | 2.02 | +12.1% | 42.7% | 0.19 | 1.43 |